Literature DB >> 26423300

The Influence of Diabetes Mellitus on Proliferation and Osteoblastic Differentiation of MSCs.

Jun Tan1,2,3, Lihua Zhou4, Yang Zhou5, Peng Xue1,2, Guangsheng Wu1,2,6, Guangying Dong1,2, Hang Guo7, Qintao Wang1,2.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is a widespread chronic metabolic disease which has high mortality due to its complications. In addition to traditional medication, stem cell transplantation therapeutics has become a brand-new and prospective remedy for DM. With strong self-renewal and multi-potential ability, mesenchymal stem cells (MSCs) are considered as ideal cell sources of cell therapy for DM and many other diseases. However, not only do endogenous MSCs fail to replace the impaired islet cells, but also transplanted MSCs fail to cure many patients complicated with DM. Besides, quite a few DM patients suffer from high risk of fracture and low efficiency of bone regeneration, which are often associated with the osteoblastic differentiation of MSCs. Recently, a number of researches have investigated that the changes in micro-environment by DM can affect biological characteristics of MSCs through many factors.
SUMMARY: In this review, we summarize the developments in the influence of DM on proliferation and osteoblastic differentiation of MSCs, and moreover, osteoporosis, obesity and metabolism syndrome, as they are closely related to DM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Diabetes mellitus; mesenchymal stem cells; metabolism syndrome; obesity; osteoblastic differentiation; osteoporosis; proliferation

Mesh:

Year:  2017        PMID: 26423300     DOI: 10.2174/1574888X10666151001114527

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  7 in total

1.  Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats.

Authors:  Yuyang Zeng; Muran Zhou; Lifeng Chen; Huimin Fang; Shaokai Liu; Chuchao Zhou; Jiaming Sun; Zhenxing Wang
Journal:  Bioact Mater       Date:  2020-06-25

2.  Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells.

Authors:  Yinuo Lin; Jinliang Nan; Jian Shen; Xinhuang Lv; Xiao Chen; Xingmei Lu; Chi Zhang; Pingping Xiang; Zhiting Wang; Zhengzheng Li
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

3.  Protective effects of low-magnitude high-frequency vibration on high glucose-induced osteoblast dysfunction and bone loss in diabetic rats.

Authors:  Zhaoyu Fu; Xu Huang; Pengcheng Zhou; Bo Wu; Long Cheng; Xinyu Wang; Dong Zhu
Journal:  J Orthop Surg Res       Date:  2021-10-30       Impact factor: 2.359

4.  PPARβ/δ accelerates bone regeneration in diabetic mellitus by enhancing AMPK/mTOR pathway-mediated autophagy.

Authors:  Miao Chen; Dian Jing; Rui Ye; Jianru Yi; Zhihe Zhao
Journal:  Stem Cell Res Ther       Date:  2021-11-04       Impact factor: 6.832

5.  High glucose inhibits the osteogenic differentiation of periodontal ligament stem cells in periodontitis by activating endoplasmic reticulum stress.

Authors:  Jun Tan; Yang Zhou; Jing Luo; Xiaoxue Wu; Haibo Liu; Weina Wang; Zebin Li; Mengyi Zhong; Lijing Wu; Xiao Li
Journal:  Ann Transl Med       Date:  2022-02

6.  A gene expression profile for the lower osteogenic potent of bone-derived MSCs from osteoporosis with T2DM and the potential mechanism.

Authors:  Sheng-Li Xia; Zi-Yuan Ma; Bin Wang; Feng Gao; Sheng-Yang Guo; Xu-Han Chen
Journal:  J Orthop Surg Res       Date:  2022-09-01       Impact factor: 2.677

7.  Irisin Promotes Osteogenesis by Modulating Oxidative Stress and Mitophagy through SIRT3 Signaling under Diabetic Conditions.

Authors:  Guangyue Li; Zixiang Jian; He Wang; Ling Xu; Tingwei Zhang; Jinlin Song
Journal:  Oxid Med Cell Longev       Date:  2022-10-10       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.